Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

BT Zhai, H Tian, J Sun, JB Zou, XF Zhang… - Journal of translational …, 2022 - Springer
Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the
treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels …

Tumor stroma as targets for cancer therapy

J Zhang, J Liu - Pharmacology & therapeutics, 2013 - Elsevier
Cancer is not only composed malignant epithelial component but also stromal components
such as fibroblasts, endothelial cells, and inflammatory cells, by which an appropriate tumor …

A covalent inhibitor of K-Ras (G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy

Z Zhang, PJ Rohweder, C Ongpipattanakul, K Basu… - Cancer Cell, 2022 - cell.com
Immunotargeting of tumor-specific antigens is a powerful therapeutic strategy.
Immunotherapies directed at MHC-I complexes have expanded the scope of antigens and …

Cryo-EM structures of the TMEM16A calcium-activated chloride channel

S Dang, S Feng, J Tien, CJ Peters, D Bulkley… - Nature, 2017 - nature.com
Calcium-activated chloride channels (CaCCs) encoded by TMEM16A,, control neuronal
signalling, smooth muscle contraction, airway and exocrine gland secretion, and rhythmic …

Fabs enable single particle cryoEM studies of small proteins

S Wu, A Avila-Sakar, JM Kim, DS Booth, CH Greenberg… - Structure, 2012 - cell.com
In spite of its recent achievements, the technique of single particle electron cryomicroscopy
(cryoEM) has not been widely used to study proteins smaller than 100 kDa, although it is a …

The urokinase receptor (uPAR) as a “Trojan Horse” in targeted cancer therapy: challenges and opportunities

V Metrangolo, M Ploug, LH Engelholm - Cancers, 2021 - mdpi.com
Simple Summary Discovered more than three decades ago, the urokinase-type
plasminogen activator receptor (uPAR) has now firmly established itself as a versatile …

Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer

L Qin, L Wang, J Zhang, H Zhou, Z Yang, Y Wang… - Science …, 2022 - science.org
The diffuse-type gastric cancer (DGC) is a subtype of gastric cancer (GC) associated with
low HER2 positivity rate and insensitivity to chemotherapy and immune checkpoint …

Immunotargeting of nanocrystals by SpyCatcher conjugation of engineered antibodies

CCS Pedroso, VR Mann, K Zuberbühler, MF Bohn… - ACS …, 2021 - ACS Publications
Inorganic nanocrystals such as quantum dots (QDs) and upconverting nanoparticles
(UCNPs) are uniquely suited for quantitative live-cell imaging and are typically …

Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer

AM LeBeau, S Duriseti, ST Murphy, F Pepin, B Hann… - Cancer research, 2013 - AACR
Components of the plasminogen activation system, which are overexpressed in aggressive
breast cancer subtypes, offer appealing targets for development of new diagnostics and …

Fibrinolytic system and cancer: diagnostic and therapeutic applications

N Mahmood, SA Rabbani - International journal of molecular sciences, 2021 - mdpi.com
Fibrinolysis is a crucial physiological process that helps to maintain a hemostatic balance by
counteracting excessive thrombosis. The components of the fibrinolytic system are well …